LA HCR8

Memorializes U.S. Congress to compel the FDA to increase inspection and testing of imported seafood, which accounts for approximately 86-94% of seafood consumed in the U.S. (valued at $25.5-$29.7 billion annually)

Cites a 2020 LSU study finding FDA-banned substances in imported shrimp sold in Baton Rouge: 70% contained nitrofurantoin, 17% fluoroquinolone, 7% oxytetracycline, and 5% malachite green

Notes FDA has not met Food Safety Modernization Act inspection targets since 2018, inspecting an average of 8,053 domestic facilities annually versus only 917 foreign facilities (FY 2018-2023)

Urges Congress to support recommendations from the January 2025 Government Accountability Office report (GAO-25-107571) on improving FDA oversight of imported seafood

Directs copies of the resolution be sent to presiding officers of Congress and all members of the Louisiana congressional delegation